Liarozole
Alternative Names: Liazal; R 75251; R 85246Latest Information Update: 19 Jul 2007
At a glance
- Originator Janssen Pharmaceutica
- Class Antineoplastics; Antipsoriatics; Imidazoles; Small molecules
- Mechanism of Action Aromatase inhibitors; Cytochrome P-450 enzyme system inhibitors; Retinoic acid metabolism modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer; Breast cancer; Ichthyosis; Prostate cancer; Psoriasis
Most Recent Events
- 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Canada (PO)
- 20 Jan 2006 Phase-II/III clinical trials in Ichthyosis in Europe (PO)
- 18 Aug 2005 Clinical development is ongoing for Ichthyosis in Europe (PO)